Exchange Traded Concepts’s NeoGenomics NEO Stock Holding History

Exchange Traded Concepts’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-104,873	Closed	-$1.27M	–	1273
2022 Q1	$1.27M	Sell	104,873 -8,134	-7%	-$171K	0.03%	299
2021 Q4	$3.86M	Buy	113,007 +22,471	+25%	+$880K	0.07%	158
2021 Q3	$4.37M	Buy	90,536 +17,904	+25%	+$829K	0.11%	117
2021 Q2	$3.28M	Buy	72,632 +9,816	+16%	+$435K	0.1%	158
2021 Q1	$3.03M	Buy	62,816 +29,497	+89%	+$1.54M	0.11%	128
2020 Q4	$1.79M	Buy	33,319 +15,982	+92%	+$722K	0.08%	164
2020 Q3	$640K	Buy	17,337 +4,786	+38%	+$178K	0.04%	243
2020 Q2	$389K	Buy	12,551 +7,468	+147%	+$207K	0.06%	246
2020 Q1	$140K	Buy	5,083 +1,792	+54%	+$53.7K	0.08%	230
2019 Q4	$96K	Buy	+3,291	New	+$78.4K	0.02%	202

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Exchange Traded Concepts's NEO Position: Q2 2022 in Review

Exchange Traded Concepts sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 104,873 shares — an estimated $1.27M sold.

Exchange Traded Concepts first reported a position in NEO in Q4 2019 and held it in 10 quarters. The position peaked at $4.37M in Q3 2021. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

Exchange Traded Concepts reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
Exchange Traded Concepts sold 104,873 NeoGenomics shares in Q2 2022, an estimated $1.27M.
Exchange Traded Concepts first reported a position in NeoGenomics in Q4 2019 and held it in 10 quarters.
Exchange Traded Concepts's NeoGenomics position peaked at $4.37M in Q3 2021.
239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Exchange Traded Concepts's 13F filing for Q2 2022, filed 20 Jul 2022.